niceritrol has been researched along with Kidney Failure, Chronic in 6 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, T | 1 |
| Ueno, T | 1 |
| Matsumoto, T | 1 |
| Watanabe, H | 1 |
| Shoji, T | 1 |
| Nishizawa, Y | 1 |
| Kawasaki, K | 1 |
| Tabata, T | 1 |
| Matsushita, Y | 1 |
| Inoue, T | 1 |
| Morii, H | 1 |
| Shimoda, K | 1 |
| Akiba, T | 1 |
| Matsushima, T | 1 |
| Rai, T | 1 |
| Abe, K | 1 |
| Hoshino, M | 1 |
| Saika, Y | 1 |
| Kodama, N | 1 |
| Kimura, K | 1 |
| Fujii, R | 1 |
| Ohtani, H | 1 |
| Mune, M | 1 |
| Mimura, K | 2 |
| Maeda, T | 1 |
| Yukawa, S | 2 |
| Wakasugi, H | 1 |
| Futami, T | 1 |
| Muso, E | 1 |
| Ono, T | 1 |
| Sasayama, S | 1 |
| Inui, K | 1 |
1 review available for niceritrol and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronar | 2004 |
1 trial available for niceritrol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effects of the nicotinic acid analogue niceritrol on lipoprotein Lp(a) and coagulation-fibrinolysis status in patients with chronic renal failure on hemodialysis.
Topics: Blood Coagulation; Female; Fibrinolysis; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Lipo | 1997 |
4 other studies available for niceritrol and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Niceritrol decreases serum phosphate levels in chronic hemodialysis patients].
Topics: Anticholesteremic Agents; Cholesterol, HDL; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; M | 1998 |
[Plasma nicotinic acid levels in hemodialysis patients after the administration of niceritrol].
Topics: Arteriosclerosis; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Lipoprotein(a); Niacin; Nic | 1999 |
Thrombocytopenia and anemia induced by niceritrol used for amelioration of hyperphosphatemia in a hemodialysis patient.
Topics: Anemia; Female; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Niceritrol; Phos | 2000 |
[Hyperlipidemia and drug treatment].
Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidn | 1991 |